InZS AssociatesbyZS·Sep 9MFN and the new geography of pricing riskWhy pricing connectivity may reshape launch sequencing and the role of some emerging markets
Darwin Gosal·Aug 8Who Pays for the Next Cure?Drug prices, national sovereignty, and the strange politics of pharmaceutical “free-riding”
Students for Patient Advocacy Nationwide·Jun 14Trump Tries Most Favored Nation Drug Pricing Again — Will it Work?A while ago, President Trump declared that “My next truth will be one of the most important and impactful I have ever issued.” A day later…
John Matthew·Oct 6, 2025Reflection-Trump’s New Enemies: Billionaires, Big Pharma, & Bibi? The David McWilliams Podcasthttps://shows.acast.com/the-david-mcwilliams-podcast/episodes/trumps-new-enemies-billionaires-big-pharma-bibi
InInsiderFinance WirebyFábio Ferreira·Oct 1, 2025TrumpRx: America’s New Direct Drug Portal — Affordable or Overhyped?In late September 2025, former President Donald Trump announced a bold initiative: TrumpRx, a government-backed website intended to let…
